Alpha Tau Medical(DRTS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

DRTS Alpha Tau Medical

Post-Mkt 06-08 17:32:20 EDT

9.28

-0.07

-0.75%

盘后9.26

-0.02-0.17%

17:28 EDT

High9.78	Low9.21	Vol597.45K
Open9.58	D1 Closing9.35	Amplitude6.10%
Mkt Cap816.73M	Tradable Cap532.24M	Total Shares88.01M
T/O5.64M	T/O Rate1.04%	Tradable Shares57.35M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"DRTS","market":"US","secType":"STK","nameCN":"Alpha Tau Medical","latestPrice":9.28,"timestamp":1780948800000,"preClose":9.35,"halted":0,"volume":597448,"hourTrading":{"tag":"盘后","latestPrice":9.264,"preClose":9.28,"latestTime":"17:28 EDT","volume":579,"amount":5388.570615,"timestamp":1780954120178,"change":-0.016,"changeRate":-0.001724,"amplitude":0.044181},"delay":0,"changeRate":-0.007486631016042812,"floatShares":57353100,"shares":88009737,"eps":-0.6603,"marketStatus":"Post-Mkt","change":-0.07,"latestTime":"06-08 17:32:20 EDT","open":9.58,"high":9.78,"low":9.21,"amount":5641276.678472,"amplitude":0.060963,"askPrice":10.25,"askSize":300,"bidPrice":9.15,"bidSize":160,"shortable":0,"etf":0,"ttmEps":-0.6603,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1780963200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":9.35,"preHourTrading":{"tag":"盘前","latestPrice":9.59,"preClose":9.35,"latestTime":"09:29 EDT","volume":11342,"amount":109547.22306100001,"timestamp":1780925399999,"change":0.24,"changeRate":0.025668,"amplitude":0.072524},"postHourTrading":{"tag":"盘后","latestPrice":9.264,"preClose":9.28,"latestTime":"17:28 EDT","volume":579,"amount":5388.570615,"timestamp":1780954120178,"change":-0.016,"changeRate":-0.001724,"amplitude":0.044181},"volumeRatio":0.326154,"impliedVol":1.3755,"impliedVolPercentile":0.6735},"requestUrl":"/m/hq/s/DRTS","defaultTab":"news","newsList":[{"id":"2641199191","title":"Top Executive Makes Major Move With Alpha Tau Medical Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2641199191","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641199191?lang=en_us&edition=fundamental","pubTime":"2026-06-05 10:08","pubTimestamp":1780625292,"startTime":"0","endTime":"0","summary":"New insider activity at Alpha Tau Medical Ltd ( ($DRTS) ) has taken place on June 4, 2026. Alpha Tau Medical Ltd has reported an insider stock tran...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-major-move-with-alpha-tau-medical-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-major-move-with-alpha-tau-medical-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DRTS","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641250161","title":"Alpha Tau Medical CFO Raphi Levy disposes of $352,606 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2641250161","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641250161?lang=en_us&edition=fundamental","pubTime":"2026-06-05 02:30","pubTimestamp":1780597815,"startTime":"0","endTime":"0","summary":"Alpha Tau Medical CFO Raphi Levy reported selling 32,500 ordinary shares on June 3.Sales priced at USD 10.76 to USD 10.9 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alpha Tau Medical Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL6gm0TT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alpha Tau Medical CFO Raphi Levy disposes of $352,606 in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRTS","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640659401","title":"Alpha Tau Medical Price Target Maintained With a $15.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2640659401","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640659401?lang=en_us&edition=fundamental","pubTime":"2026-06-04 22:58","pubTimestamp":1780585080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DRTS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 04, 2026 10:58 ET (14:58 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640315004","title":"Alpha Tau Medical Is Maintained at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2640315004","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640315004?lang=en_us&edition=fundamental","pubTime":"2026-06-04 21:08","pubTimestamp":1780578480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DRTS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 04, 2026 09:08 ET (13:08 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640685153","title":"Alpha Tau Medical Ltd (DRTS) Receives a Buy from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2640685153","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640685153?lang=en_us&edition=fundamental","pubTime":"2026-06-04 16:37","pubTimestamp":1780562238,"startTime":"0","endTime":"0","summary":"Barclays analyst Lukas Shumway maintained a Buy rating on Alpha Tau Medical Ltd today and set a price target of $17.00. According to TipRanks, Shum...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/alpha-tau-medical-ltd-drts-receives-a-buy-from-barclays-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/alpha-tau-medical-ltd-drts-receives-a-buy-from-barclays-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DRTS","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640188960","title":"Alpha Tau, Tolmar announce strategic collaboration agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2640188960","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640188960?lang=en_us&edition=fundamental","pubTime":"2026-06-03 22:53","pubTimestamp":1780498382,"startTime":"0","endTime":"0","summary":"Alpha Tau (DRTS) and Tolmar announced a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate can...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alpha-tau-tolmar-announce-strategic-collaboration-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alpha-tau-tolmar-announce-strategic-collaboration-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DRTS","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640900394","title":"Alpha Tau Medical, Tolmar International Agree to Develop, Commercialize Prostate Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2640900394","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640900394?lang=en_us&edition=fundamental","pubTime":"2026-06-03 22:03","pubTimestamp":1780495418,"startTime":"0","endTime":"0","summary":"Alpha Tau Medical (DRTS) and Tolmar International have agreed to develop and commercialize Alpha DaRT therapy for the treatment of prostate cancer in the US, the companies said Wednesday.Under the agr","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4231","DRTS","BK4082","ADC","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640686904","title":"Alpha Tau, Tolmar partner to develop, commercialize Alpha DaRT for U.S. prostate cancer patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2640686904","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640686904?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:33","pubTimestamp":1780490030,"startTime":"0","endTime":"0","summary":"Alpha Tau Medical entered a strategic collaboration with Tolmar to develop and commercialize Alpha DaRT for U.S. prostate cancer.Tolmar gets exclusive U.S. commercialization rights for prostate cancer for about 20 years from first sale.Tolmar invested USD 20 million in equity at USD 11.99 a share; paid USD 15 million toward a new U.S. production facility.Deal includes up to USD 161.5 million in clinical, regulatory, and commercial milestones for the first indication.Alpha Tau will manufacture and supply product at 60% of onward net sales; Tolmar holds a bladder cancer option tied to criteria.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL2dPy16:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BN0W2T93.GBP","LU0314104364.USD","SG9999014005.SGD","NDAQ","IE00BGHQF748.EUR","SG9999014039.USD","DRTS","IE00B3QW5Z07.USD","LU2210150020.SGD","SG9999014013.SGD","IE00BN0W2W23.USD","LU2210149790.SGD","SG9999014021.USD","BK4082","BK4112","IE00B64PRP62.GBP","BK4588","IE00BKPKM429.USD","IE00BN0W2V16.EUR","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640904377","title":"Alpha Tau Medical - Tolmar Granted Exclusive U.S. Rights for Prostate Cancer, Option for Bladder Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2640904377","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640904377?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:30","pubTimestamp":1780489802,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA3DSVYQ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","DRTSW","DRTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640904374","title":"Alpha Tau Medical - Tolmar to Invest $15M in Manufacturing, $20M Equity at $11.99/Share, up to $161.5M in Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2640904374","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640904374?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:30","pubTimestamp":1780489802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA3DSVYQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DRTS","BK4082","DRTSW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640690430","title":"Alpha Tau Medical - to Manufacture Alpha Dart for Tolmar at 60% of Net Sales Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2640690430","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640690430?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:30","pubTimestamp":1780489802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA3DSVYQ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DRTS","DRTSW","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640045999","title":"Alpha Tau Medical - up to $96.5M in Development and $65M in Commercial Milestone Payments Agreed","url":"https://stock-news.laohu8.com/highlight/detail?id=2640045999","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640045999?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:30","pubTimestamp":1780489802,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA3DSVYQ:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DRTS","BK4082","DRTSW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640942420","title":"Alpha Tau Medical Price Target Maintained With a $15.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2640942420","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640942420?lang=en_us&edition=fundamental","pubTime":"2026-06-03 00:49","pubTimestamp":1780418940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DRTS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 02, 2026 12:49 ET (16:49 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640311957","title":"Alpha Tau Medical Reports Data Showing Alpha DaRT Increases Overall Survival for Patients With Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2640311957","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640311957?lang=en_us&edition=fundamental","pubTime":"2026-06-01 21:50","pubTimestamp":1780321852,"startTime":"0","endTime":"0","summary":"Alpha Tau Medical (DRTS) said Monday that data from a pooled analysis of three prospective phase 1/2 trials of its Alpha DaRT device to treat advanced pancreatic cancer, exceeded the overall survival ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DRTS","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640954102","title":"Alpha Tau reports 11.2-month median survival in pooled Phase I/II Alpha DaRT pancreatic cancer studies at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640954102","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640954102?lang=en_us&edition=fundamental","pubTime":"2026-06-01 21:01","pubTimestamp":1780318905,"startTime":"0","endTime":"0","summary":"Alpha Tau Medical reported overall survival results from pooled early-stage pancreatic cancer studies, presented at the 2026 ASCO Annual Meeting.Findings indicated patients lived longer than expected across several prior-treatment settings, supporting the therapy’s potential clinical benefit.Safety was described as favorable, with limited severe side effects, no treatment-related deaths, no chronic toxicity reported.Focus now shifts to completing enrollment in the U.S. IMPACT trial testing Alpha DaRT with first-line chemotherapy in newly diagnosed unresectable disease.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alpha Tau Medical Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gath","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL48RCbn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","DRTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640954189","title":"Alpha Tau Announces Strong Overall Survival Results From Alpha Dart® Pancreatic Cancer Studies Presented at 2026 Asco Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2640954189","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640954189?lang=en_us&edition=fundamental","pubTime":"2026-06-01 21:00","pubTimestamp":1780318802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nTUA1MVCB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DRTSW","DRTS","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640305719","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2640305719","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640305719?lang=en_us&edition=fundamental","pubTime":"2026-06-01 17:31","pubTimestamp":1780306300,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Gilead Sciences (GILD) and Alpha Tau Medical Ltd (DR...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-195?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-195?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0861579265.USD","BK4568","IE00B19Z3B42.SGD","LU1037948897.HKD","LU0965508806.USD","LU0965509283.SGD","BK4139","LU1023059063.AUD","LU0320765992.SGD","LU1061106388.HKD","LU0289739699.SGD","LU1430594728.SGD","LU1674673428.USD","IE00B7SZLL34.SGD","SG9999015952.SGD","IE00BZ1G4Q59.USD","LU1066051498.USD","LU0234570918.USD","LU1778281490.HKD","BK4550","IE00B3T34201.USD","LU1674673691.USD","LU1585245621.USD","LU1839511570.USD","LU1571399168.USD","LU0823416689.USD","LU0114720955.EUR","BK4566","LU0109394709.USD","IE0002270589.USD","LU0882574055.USD","BK4588","LU2324357040.USD","LU2112291526.USD","SG9999015945.SGD","SG9999015978.USD","BK4532","GILD","LU1934455194.USD","LU2087621335.USD","LU0889565916.HKD","BK4082","LU0058720904.USD","LU1037948541.HKD","BK4578","DRTS","BK4585","IE00BSNM7G36.USD","BK4583","LU0122379950.USD","SG9999015986.USD","IE00BKVL7J92.USD","IE00B19Z3581.USD","LU1057294990.SGD","LU1934455277.USD","LU1066053197.SGD","LU0965509101.SGD","LU2468319806.SGD","LU2089984988.USD","LU1934455863.HKD","LU0965509010.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638699603","title":"Alpha Tau Medical Initiated at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2638699603","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638699603?lang=en_us&edition=fundamental","pubTime":"2026-05-28 21:43","pubTimestamp":1779975780,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DRTS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 28, 2026 09:43 ET (13:43 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638566035","title":"Barclays Initiates Alpha Tau Medical With Overweight Rating, $15 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2638566035","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638566035?lang=en_us&edition=fundamental","pubTime":"2026-05-28 19:16","pubTimestamp":1779966960,"startTime":"0","endTime":"0","summary":"Alpha Tau Medical (DRTS) has an average rating of overweight and mean price target of $13.80, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DRTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638266122","title":"Alpha Tau :  Barclays Initiates Coverage With Overweight Rating  and Target Price $15","url":"https://stock-news.laohu8.com/highlight/detail?id=2638266122","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638266122?lang=en_us&edition=fundamental","pubTime":"2026-05-28 17:53","pubTimestamp":1779962034,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nAZN4SZ2BS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DRTS","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alphatau.com","stockEarnings":[{"period":"1week","weight":-0.1367},{"period":"1month","weight":0.2319},{"period":"3month","weight":0.4587},{"period":"6month","weight":1.4036},{"period":"1year","weight":2.3274},{"period":"ytd","weight":0.8889}],"compareEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":0.0051},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.0756},{"period":"1year","weight":0.2437},{"period":"ytd","weight":0.0816}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.237533},{"month":2,"riseRate":0.25,"avgChangeRate":-0.092011},{"month":3,"riseRate":0,"avgChangeRate":-0.091558},{"month":4,"riseRate":0.6,"avgChangeRate":-0.032951},{"month":5,"riseRate":0.8,"avgChangeRate":0.134883},{"month":6,"riseRate":0.8,"avgChangeRate":0.036275},{"month":7,"riseRate":0.25,"avgChangeRate":-0.00683},{"month":8,"riseRate":0.5,"avgChangeRate":-0.059828},{"month":9,"riseRate":0.5,"avgChangeRate":0.052507},{"month":10,"riseRate":0,"avgChangeRate":-0.106065},{"month":11,"riseRate":0.25,"avgChangeRate":0.002718},{"month":12,"riseRate":0.5,"avgChangeRate":0.017167}],"exchange":"NASDAQ","name":"Alpha Tau Medical","nameEN":"Alpha Tau Medical"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Alpha Tau Medical(DRTS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Alpha Tau Medical(DRTS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Alpha Tau Medical,DRTS,Alpha Tau Medical股票,Alpha Tau Medical股票老虎,Alpha Tau Medical股票老虎国际,Alpha Tau Medical行情,Alpha Tau Medical股票行情,Alpha Tau Medical股价,Alpha Tau Medical股市,Alpha Tau Medical股票价格,Alpha Tau Medical股票交易,Alpha Tau Medical股票购买,Alpha Tau Medical股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Alpha Tau Medical(DRTS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Alpha Tau Medical(DRTS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction